Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Operating Expenses (2022 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Other Operating Expenses for 3 consecutive years, with -$40.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to -$40.7 million, compared with a TTM value of -$168.8 million through Dec 2025, down 14.88%, and an annual FY2025 reading of -$168.8 million, changed N/A over the prior year.
  • Other Operating Expenses was -$40.7 million for Q4 2025 at Arcturus Therapeutics Holdings, up from -$79.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$40.7 million in Q4 2025 and bottomed at -$79.1 million in Q3 2025.